Company intelligence / Profile preview
Redona Therapeutics
Watertown, Massachusetts, United Statesredonatx.com ↗
- Ownership
- Private
- Employees
- ~12
- Development stage
- Other
01
Overview
Redona Therapeutics develops novel small molecule therapeutics that modulate the function and expression levels of disease-relevant genes by targeting non-coding RNAs and their associated regulatory proteins. The company’s approach focuses on enzymes involved in the dysregulation of both RNA and DNA processes implicated in cancer and other serious diseases. As a platform biotech founded by leading scientists in the field, Redona has raised significant venture funding but has not yet reported clinical trial results or late-stage pipeline assets.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small molecules targeting RNA-modulating proteins (RMPs)Modulation of non-coding RNAs (ncRNAs)Targeting enzymes involved in RNA and DNA processes
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Redona Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Redona Therapeutics.